SHA:600812 Market Cap

SHA:600812 has a market cap or net worth of 9.04 billion as of April 29, 2026. Its market cap has decreased by -16.88% in one year.

Market Cap

9.04B

Enterprise Value

20.28B

Revenue

8.82B

Ranking

n/a

PE Ratio

55.97

Stock Price

5.27

Market Cap Chart

Since August 28, 2006, SHA:600812's market cap has increased from 2.00B to 9.04B, an increase of 353.13%. That is a compound annual growth rate of 7.98%.

Market Cap History

Date	Market Cap	% Change
Apr 29, 2026	9.04B	-4.70%
Dec 31, 2025	9.49B	6.96%
Dec 31, 2024	8.87B	-9.30%
Dec 29, 2023	9.78B	-10.94%
Dec 30, 2022	10.98B	-46.31%
Dec 31, 2021	20.45B	21.87%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Changzhou Qianhong Biopharma CO.,LTD	9.12B
Harbin Pharmaceutical Group	9.32B
PharmaBlock Sciences (Nanjing)	8.89B
Shenzhen Neptunus Bioengineering	8.81B
Zhejiang Xianju Pharmaceutical	8.79B
Chongqing Taiji Industry(Group) Co.,Ltd	8.74B
Hubei Hongyuan Pharmaceutical Technology	9.71B
Beijing Foyou Pharma CO.,LTD	9.79B

Market Cap Rankings